ProKidney Corp. Class A Ordinary Shares (PROK) is a publicly traded Healthcare sector company. As of May 21, 2026, PROK trades at $1.74 with a market cap of $330.37M and a P/E ratio of 0.00. PROK moved +10.65% today. Year to date, PROK is -21.03%; over the trailing twelve months it is +113.01%. Its 52-week range spans $0.46 to $7.13. Analyst consensus is neutral with an average price target of $7.33. Rallies surfaces PROK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PROK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PROK recently traded at $1.74. Market cap is $330.37M. P/E ratio is 0.00. Revenue is $893.00K.
| Metric | Value |
|---|---|
| Price | $1.74 |
| Market Cap | $330.37M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.13 |
| 52-Week Low | $0.46 |
| Volume | 290 |
| Avg Volume | 0 |
| Revenue (TTM) | $893.00K |
| Net Income | $-151.61M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $893.00K | $-151.61M | $0.00 |
| 2024 | $76.00K | $-163.34M | $0.00 |
| 2023 | $0 | $-135.45M | $0.00 |
| 2022 | $0 | $-148.13M | $-0.23 |
5 analysts cover PROK: 0 strong buy, 2 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.33.